C12Y116/01001

METHOD, SYSTEM, AND COMPOSITION OF MATTER FOR REDUCING TOXIC MERCURY IN WASTEWATER EFFLUENT
20230087150 · 2023-03-23 ·

A method for reducing toxic mercury in wastewater effluent comprises the steps of: identifying a system into which wastewater effluent is introduced, the wastewater effluent including organic compounds and organomercurial compounds; producing a treatment composition comprising a solution including a surfactant, digestive microbes suspended in the solution, and mercury-transformative microbes suspended in the solution; and providing the treatment composition into the system containing the wastewater effluent, such that the digestive microbes degrade the organic compounds in the wastewater effluent, and the mercury-transformative microbes reduce the organomercurial compounds in the wastewater effluent into nontoxic volatile elemental mercury. In certain systems for reducing toxic mercury in wastewater effluent, a biological capture medium is positioned within a vessel and configured to provide a capture point for microbes to adhere to and create biofilms. One such system is a dental evacuation system in which wastewater effluent is introduced into the system via an aspirator.

USING SYNTHETIC LIXIVIANT BIOLOGY FOR THE RECOVERY OF PRECIOUS AND TOXIC METALS FROM ANTHROPOGENIC SOURCES

The present invention generally relates to methods of biological reduction of metal-cyanide complexes after metal-cyanidation and methods of biologically hydrolysing cyanide. More particularly, the present invention allows the engineering of an integrated synthetic lixiviant biological system to be housed within a synthetic host (such as the cyanogenic Chromobacterium violaceum) for efficient precious metal recovery and toxic metal remediation of electronic waste; with up to four main components/modules in the design and engineering of the synthetic host: 1) synthetic cyanogenesis; 2) synthetic metal recovery; 3) synthetic cyanolysis; and 4) synthetic circuits for lixiviant biology. Bacteria capable of reducing ionic metal to ionic metal (such as gold or silver) as nanoparticles, comprising mercury(ll) reductase (MerA) comprising a substitution mutation at position V317, Y441, C464, A323D, A414E, G415I, E416C, L417I, I418D, or A422N, are also disclosed. Processes of synthetic cyanide lixiviant production using genetically engineered bacterium transformed with a heterologous hydrogen cyanide synthase gene and a heterologous 3-phosphoglycerate dehydrogenase mutant gene are also disclosed. Processes of synthetic cyanolysis using a genetically engineered bacterium transformed with a heterologous nitrilase gene are also disclosed.

Method, system, and composition of matter for reducing toxic mercury in wastewater effluent

A method for reducing toxic mercury in wastewater effluent comprises the steps of: identifying a system into which wastewater effluent is introduced, the wastewater effluent including organic compounds and organomercurial compounds; producing a treatment composition comprising a solution including a surfactant, digestive microbes suspended in the solution, and mercury-transformative microbes suspended in the solution; and providing the treatment composition into the system containing the wastewater effluent, such that the digestive microbes degrade the organic compounds in the wastewater effluent, and the mercury-transformative microbes reduce the organomercurial compounds in the wastewater effluent into nontoxic volatile elemental mercury. In certain systems for reducing toxic mercury in wastewater effluent, a biological capture medium is positioned within a vessel and configured to provide a capture point for microbes to adhere to and create biofilms. One such system is a dental evacuation system in which wastewater effluent is introduced into the system via an aspirator.

TRANSGENIC ANIMALS FOR MERCURY BIOREMEDIATION
20250248378 · 2025-08-07 ·

There is provided a transgenic animal comprising heterologous nucleic acid encoding a bacterial organomercurial lyase and/or a bacterial mercuric reductase, wherein the transgenic animal expresses the bacterial organomercurial lyase and/or a bacterial mercuric reductase to reduce the toxicity of a mercury compound.

FUNGUS AND MICROBIAL AGENT FOR TREATING MERCURY CONTAMINATION, USE THEREOF, MERCURY REMOVAL METHOD, AND METHOD FOR IDENTIFYING FUNGUS CAPABLE OF TREATING MERCURY CONTAMINATION
20250263650 · 2025-08-21 ·

The present disclosure provides a fungus and a microbial agent for treating mercury contamination, use thereof, a mercury removal method, and a method for identifying a fungus capable of treating mercury contamination, and relates to the technical field of biological mercury removal. The present disclosure provides a Metarhizium fungus and 8 species of non-Metarhizium fungi for treating mercury contamination, a method for identifying a fungus capable of treating mercury contamination, and enzymes for removing methylmercury and divalent mercury, which provides a genetic basis for treating mercury contamination with recombinant fungi or bacteria.

Using synthetic lixiviant biology for the recovery of precious and toxic metals from anthropogenic sources

The present invention generally relates to methods of biological reduction of metal-cyanide complexes after metal-cyanidation and methods of biologically hydrolysing cyanide. More particularly, the present invention allows the engineering of an integrated synthetic lixiviant biological system to be housed within a synthetic host (such as the cyanogenic Chromobacterium violaceum) for efficient precious metal recovery and toxic metal remediation of electronic waste; with up to four main components/modules in the design and engineering of the synthetic host: 1) synthetic cyanogenesis; 2) synthetic metal recovery; 3) synthetic cyanolysis; and 4) synthetic circuits for lixiviant biology. Bacteria capable of reducing ionic metal to ionic metal (such as gold or silver) as nanoparticles, comprising mercury(11) reductase (MerA) comprising a substitution mutation at position V317, Y441, C464, A323D, A414E, G415I, E416C, L417I, I418D, or A422N, are also disclosed. Processes of synthetic cyanide lixiviant production using genetically engineered bacterium transformed with a heterologous hydrogen cyanide synthase gene and a heterologous 3-phosphoglycerate dehydrogenase mutant gene are also disclosed. Processes of synthetic cyanolysis using a genetically engineered bacterium transformed with a heterologous nitrilase gene are also disclosed.